Preventing Central Catheter-Associated Bloodstream Infections
NCT ID: NCT04920877
Last Updated: 2021-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2021-06-04
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Phlebitis, Infiltration and Extravasation With Infusion Monitoring System
NCT07046624
Artificial Intelligence With Determination of Central Venous Catheter Line Associated Infection Risk
NCT05914571
Daily Ultrasound-screening for CVC-related Thrombosis
NCT03327376
Ultrasound-Guided Peripheral Intravenous Access by Critical Nurses.
NCT02285712
Comparison of Two Approach in Ultrasound Guided Central Venous Catheterizations
NCT05409768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Nurse-focused algorithm content to prevent central catheter-related bloodstream infections Hand hygiene practice Use of personal protective equipment according to infection control measures Evaluation of the catheter insertion site in terms of redness, swelling, tenderness, discharge, bleeding Use of \>0.5% chlorhexidine solution containing 70% alcohol for skin antisepsis at the catheter insertion site (if there is no chlorhexidine, povidone iodine + 70% alcohol solution is used) Changing the transparent, semi-permeable dressings every 5-7 days and gauze dressings every 48 hours for catheter dressing Catheter dressing with aseptic technique Use of sterile, preservative-free saline for flushing and locking in order to ensure the lumen of the catheter.
Aseptic conditions should be observed if the junction of the catheter and the infusion set (Hub) is to be touched.
Keeping the used triple taps closed Changing IV fluid sets and connection tools at appropriate times Daily assessment of CVC requirement The research will be carried out in the 1st, 2nd and 3rd Level Intensive Care Units of Bilecik Training and Research Hospital in Bilecik, Turkey. Infection rates will be compared in the study. In the study, the date of June 2021 will be taken as a preliminary assessment and training time for nurses. July-September 2021 will be the intervention period of the study, and October-December 2021 will be the post-intervention period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Central catheter-related bloodstream infection rates in intensive care units
Infection Prevention
Preventing central catheter-related bloodstream infections in intensive care units
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infection Prevention
Preventing central catheter-related bloodstream infections in intensive care units
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aysun ACUN
Research Assistant
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIBU-SBF-AA-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.